The COVID-19 Lobster Trap

Co-Moderator(s)

• 

  Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his)

  Professor of Pharmaco- and Device Epidemiology, Professor of RWE
  University of Oxford, Erasmus MC University
  University of Oxford
  Oxford, United Kingdom
• 

  Daniela Moga, MD, PhD (she/her/hers)

  Associate Professor
  Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky, USA
  Lexington, United States

Presentations:

• 1:30 PM – 1:45 PM ADT

  Impact of the COVID-19 Pandemic in the Netherlands on Primary Healthcare Use and Clinical Outcomes in People With Type 2 Diabetes
  

  Presenting Author: Jesse M. van den Berg, MD (he/him/his) – PHARMO Institute for Drug Outcomes Research
• 1:45 PM – 2:00 PM ADT

  Impact of COVID-19 Pandemic Restrictions on Diagnosis and Treatment of Hypertension in the United Kingdom
  

  Presenting Author: Kyle Johnson, MSc – Mcgill University Department of Epidemiology, Biostatistics, and Occupational Health
• 2:00 PM – 2:15 PM ADT

  Impact of the COVID-19 Pandemic on Drug Shortage Incidence in the United States
  

  Presenting Author: Katherine Callaway Kim, MPH – Department of Medicine, Division of General Internal Medicine, University of Pittsburgh School of MedicineDepartment of Health Policy and Management, University of Pittsburgh School of Public Health
• 2:15 PM – 2:30 PM ADT

  A dynamic prognostic model for identifying vulnerable COVID-19 patients at high risk of rapid deterioration
  

  Presenting Author: Priyanka Anand, MBBS, MPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital
• 2:30 PM – 2:45 PM ADT

  Hospitalized Arterial and Venous Thrombotic Events in Patients Diagnosed in the Ambulatory Setting with COVID-19 Compared to Influenza
  

  Presenting Author: Noelle M. Cocoros, DSc, MPH (she/her/hers) – Harvard Pilgrim Health Care Institute
• 2:45 PM – 3:00 PM ADT

  Defining Post-COVID Conditions Using Changes in Symptomatology in Electronic Health Record Data from the United States
  

  Presenting Author: Kathleen M. Andersen, PhD (she/her/hers) – Pfizer